AstraZeneca Ad Minimizes Risks Posed By Highest Crestor Dose, FDA Says
This article was originally published in The Pink Sheet Daily
Executive Summary
AstraZeneca's newspaper ads defending the safety of Crestor minimized the risks associated with the 40 mg dose of the statin, FDA says in a Dec. 21 "untitled" letter to the company